Yuhang Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuhang Ma has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Xiaoying Ding
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
4 shared publications - Yongde Peng
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University, 100 Haining Road, Shanghai 200080, China
3 shared publications Na Li
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications- Na Li
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
2 shared publications Xiaohui Wei
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, People’s Republic of China
2 shared publicationsXuejiao Wang
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China
2 shared publications
Latest Publications
- Open Access
- 9 March 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1790281
COVID-19 associated CKM syndrome progression in diabetic patients is linked to pancreatic beta cell dysfunction, rather than RASi use: a retrospective cohort study
Background and aims: SARS-CoV-2 primarily has tissue tropism for the respiratory epithelium; however, it may cause multiple organ dysfunction due to the widespread expression of its entry receptor, ACE2. Specifically, SARS-CoV-2 may enter pancreatic β-cells by exploiting ACE2, disrupting cellular and hormonal activity, and thereby worsening Cardiovascular-Kidney-Metabolic (CKM) syndrome prognosis in diabetic patients. Furthermore, treatment with renin-angiotensin system inhibitors (RASi) may arguably increase ACE2 expression and facilitate viral entry, making its independent impact highly debated. Accordingly, we sought to elucidate the genuine impact of RASi usage on CKM progression via Propensity Score Matching (PSM) and concurrently investigate the specific contribution of pancreatic β-cell secretory dysfunction. Methods: We conducted a retrospective investigation involving 682 diabetic patients across CKM stages 2 to 4 with confirmed SARS-CoV-2 infection utilizing multivariate logistic regression coupled with 1:1 PSM to rectify selection bias concerning RASi administration and identifying predictors. Results: Post-infection CKM progression was observed in 25.2% of the cohort and while initial multivariate models implicated RASi (OR = 1.56, 95% CI: 1.06–2.28; p=0.02) as a risk factor this association lost statistical significance after rigorously balancing baseline characteristics through PSM (OR = 1.56, 95% CI: 0.91–2.67; p = 0.156). A paradoxical finding emerged wherein the progression group exhibited low HOMA-IR scores accompanied by reduced fasting C-peptide and elevated glucose thereby indicating severe viral-induced β-cell secretory dysfunction rather than enhanced insulin sensitivity while High-Density Lipoprotein Cholesterol (HDL-C) persisted as a protective factor. Conclusions: COVID-19 exacerbates CKM progression in diabetic patients, but this is not driven by RASi therapy itself. RASi use should be interpreted as a “marker of severity” for baseline comorbidities, rather than a pathogenic factor. Mechanistically, viral infection may cause the failure of compensatory mechanisms in pancreatic β-cell function (manifested as low C-peptide and spurious low HOMA-IR).
- 9 March 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1790281
Open AccessCOVID-19 associated CKM syndrome progression in diabetic patients is linked to pancreatic beta cell dysfunction, rather than RASi use: a retrospective cohort study
Background and aims: SARS-CoV-2 primarily has tissue tropism for the respiratory epithelium; however, it may cause multiple organ dysfunction due to the widespread expression of its entry receptor, ACE2. Specifically, SARS-CoV-2 may enter pancreatic β-cells by exploiting ACE2, disrupting cellular and hormonal activity, and thereby worsening Cardiovascular-Kidney-Metabolic (CKM) syndrome prognosis in diabetic patients. Furthermore, treatment with renin-angiotensin system inhibitors (RASi) may arguably increase ACE2 expression and facilitate viral entry, making its independent impact highly debated. Accordingly, we sought to elucidate the genuine impact of RASi usage on CKM progression via Propensity Score Matching (PSM) and concurrently investigate the specific contribution of pancreatic β-cell secretory dysfunction. Methods: We conducted a retrospective investigation involving 682 diabetic patients across CKM stages 2 to 4 with confirmed SARS-CoV-2 infection utilizing multivariate logistic regression coupled with 1:1 PSM to rectify selection bias concerning RASi administration and identifying predictors. Results: Post-infection CKM progression was observed in 25.2% of the cohort and while initial multivariate models implicated RASi (OR = 1.56, 95% CI: 1.06–2.28; p=0.02) as a risk factor this association lost statistical significance after rigorously balancing baseline characteristics through PSM (OR = 1.56, 95% CI: 0.91–2.67; p = 0.156). A paradoxical finding emerged wherein the progression group exhibited low HOMA-IR scores accompanied by reduced fasting C-peptide and elevated glucose thereby indicating severe viral-induced β-cell secretory dysfunction rather than enhanced insulin sensitivity while High-Density Lipoprotein Cholesterol (HDL-C) persisted as a protective factor. Conclusions: COVID-19 exacerbates CKM progression in diabetic patients, but this is not driven by RASi therapy itself. RASi use should be interpreted as a “marker of severity” for baseline comorbidities, rather than a pathogenic factor. Mechanistically, viral infection may cause the failure of compensatory mechanisms in pancreatic β-cell function (manifested as low C-peptide and spurious low HOMA-IR).
- Open Access
- 26 August 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1609144
Alcohol consumption, high-sensitivity C-reactive protein, and estimated glomerular filtration rate: tripartite predictors of 10-year cardiovascular risk progression in patients with type 2 diabetes mellitus after COVID-19
Objectives: To investigate the predictors influencing the advancement of 10-year cardiovascular disease (CVD) risk after infection with Corona Virus Disease 2019 (COVID-19) in type 2 diabetes patients, and to provide a theoretical basis for an early intervention program for the cardiovascular dimension of the cardiovascular-kidney-metabolic syndrome (CKM syndrome).Methods: A cohort of 378 individuals diagnosed with type 2 diabetes was analyzed retrospectively. The progression of 10-year CVD risk was characterized by an elevation in the 10-year CVD risk category, as determined by the SCORE2-Diabetes scoring system, in type 2 diabetic infected with COVID-19. Factors influencing 10-year CVD risk progression were evaluated through univariate and multivariate stepwise logistic regression. Nonlinear relationships between predictors and 10-year CVD progression were assessed using restricted cubic spline (RCS) analysis, subsequently followed by an analysis of threshold effects. Finally, the predictive performance of various factor combinations for 10-year CVD risk progression during the post-acute COVID-19 phase in type 2 diabetes mellitus cohorts was measured by area under roc curve (AUC).Results: After infection with COVID-19, 12.2% (n=46) experienced progression in their 10-year CVD risk category. In multifactorial stepwise logistic regression, alcohol consumption [odds ratio (OR) 2.10, 95% confidence interval (CI) 1.02-4.34], estimated glomerular filtration rate (eGFR) (OR 0.96, 95% CI 0.94-0.99) and high-sensitivity C-reactive protein (hs-CRP) (OR 1.33, 95% CI 1.13-1.57), were found to be significantly linked to the progression of 10-year CVD risk. Restricted cubic spline analysis (RCS) demonstrated a nonlinear correlation between hs-CRP and 10-year CVD risk progression with a threshold of 3.0 mg/L. 10-year CVD risk was significantly higher with increasing hs-CRP levels at hs-CRP < 3.0 mg/L (OR 2.28, 95% CI 1.48-3.55), and the two-stage model significantly superior to a single linear model (P = 0.028 for log-likelihood ratio). Among the different combinations of models for alcohol consumption, hs-CRP, and eGFR, the full model combination of all three had the best predictive effect (AUC = 0.749).Conclusion: Alcohol consumption and elevated hs-CRP were associated with increased cardiovascular risk progression, while higher eGFR levels were inversely associated with risk progression.
- 26 August 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1609144
Open AccessAlcohol consumption, high-sensitivity C-reactive protein, and estimated glomerular filtration rate: tripartite predictors of 10-year cardiovascular risk progression in patients with type 2 diabetes mellitus after COVID-19
Objectives: To investigate the predictors influencing the advancement of 10-year cardiovascular disease (CVD) risk after infection with Corona Virus Disease 2019 (COVID-19) in type 2 diabetes patients, and to provide a theoretical basis for an early intervention program for the cardiovascular dimension of the cardiovascular-kidney-metabolic syndrome (CKM syndrome).Methods: A cohort of 378 individuals diagnosed with type 2 diabetes was analyzed retrospectively. The progression of 10-year CVD risk was characterized by an elevation in the 10-year CVD risk category, as determined by the SCORE2-Diabetes scoring system, in type 2 diabetic infected with COVID-19. Factors influencing 10-year CVD risk progression were evaluated through univariate and multivariate stepwise logistic regression. Nonlinear relationships between predictors and 10-year CVD progression were assessed using restricted cubic spline (RCS) analysis, subsequently followed by an analysis of threshold effects. Finally, the predictive performance of various factor combinations for 10-year CVD risk progression during the post-acute COVID-19 phase in type 2 diabetes mellitus cohorts was measured by area under roc curve (AUC).Results: After infection with COVID-19, 12.2% (n=46) experienced progression in their 10-year CVD risk category. In multifactorial stepwise logistic regression, alcohol consumption [odds ratio (OR) 2.10, 95% confidence interval (CI) 1.02-4.34], estimated glomerular filtration rate (eGFR) (OR 0.96, 95% CI 0.94-0.99) and high-sensitivity C-reactive protein (hs-CRP) (OR 1.33, 95% CI 1.13-1.57), were found to be significantly linked to the progression of 10-year CVD risk. Restricted cubic spline analysis (RCS) demonstrated a nonlinear correlation between hs-CRP and 10-year CVD risk progression with a threshold of 3.0 mg/L. 10-year CVD risk was significantly higher with increasing hs-CRP levels at hs-CRP < 3.0 mg/L (OR 2.28, 95% CI 1.48-3.55), and the two-stage model significantly superior to a single linear model (P = 0.028 for log-likelihood ratio). Among the different combinations of models for alcohol consumption, hs-CRP, and eGFR, the full model combination of all three had the best predictive effect (AUC = 0.749).Conclusion: Alcohol consumption and elevated hs-CRP were associated with increased cardiovascular risk progression, while higher eGFR levels were inversely associated with risk progression.
- Open Access
- 17 March 2023
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 108 (6) , 945-959
Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue
Polycystic ovary syndrome is a complicated hormonal and metabolic disorder. The exact pathogenesis of polycystic ovary syndrome is not clear thus far. Inflammation is involved in the progression of polycystic ovary syndrome. In addition, brown adipose tissue activity is impaired in polycystic ovary syndrome. Interestingly, glucagon-like peptide-1 receptor agonists have been reported to alleviate inflammation and promote browning of white adipose tissue. In this study, the effects of glucagon-like peptide-1 receptor agonists on polycystic ovary syndrome mice were explored. Mice were randomly assigned into four groups: control, dehydroepiandrosterone, dehydroepiandrosterone + liraglutide, and dehydroepiandrosterone + semaglutide. Relative indexes were measured after glucagon-like peptide-1 receptor agonist intervention. Glucose metabolism in polycystic ovary syndrome mice was ameliorated by glucagon-like peptide-1 receptor agonists, while the reproductive endocrine disorder of polycystic ovary syndrome mice was partially reversed. The messenger ribonucleic acid levels of steroidogenic enzymes and the expression of inflammatory mediators in serum and ovaries of polycystic ovary syndrome mice were improved. Furthermore, toll-like receptor 4 and phosphorylation of nuclear factor-kappa B protein levels were decreased by glucagon-like peptide-1 receptor agonists in ovary. Notably, after glucagon-like peptide-1 receptor agonist intervention, the expression of brown adipose tissue marker levels was considerably raised in the white adipose tissue of polycystic ovary syndrome mice. In conclusion, the hyperinsulinemia and hyperandrogenemia of polycystic ovary syndrome mice were alleviated by glucagon-like peptide-1 receptor agonist intervention, which was associated with mitigating inflammation and stimulating adipose tissue browning.
- 17 March 2023
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 108 (6) , 945-959
Open AccessGlucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue
Polycystic ovary syndrome is a complicated hormonal and metabolic disorder. The exact pathogenesis of polycystic ovary syndrome is not clear thus far. Inflammation is involved in the progression of polycystic ovary syndrome. In addition, brown adipose tissue activity is impaired in polycystic ovary syndrome. Interestingly, glucagon-like peptide-1 receptor agonists have been reported to alleviate inflammation and promote browning of white adipose tissue. In this study, the effects of glucagon-like peptide-1 receptor agonists on polycystic ovary syndrome mice were explored. Mice were randomly assigned into four groups: control, dehydroepiandrosterone, dehydroepiandrosterone + liraglutide, and dehydroepiandrosterone + semaglutide. Relative indexes were measured after glucagon-like peptide-1 receptor agonist intervention. Glucose metabolism in polycystic ovary syndrome mice was ameliorated by glucagon-like peptide-1 receptor agonists, while the reproductive endocrine disorder of polycystic ovary syndrome mice was partially reversed. The messenger ribonucleic acid levels of steroidogenic enzymes and the expression of inflammatory mediators in serum and ovaries of polycystic ovary syndrome mice were improved. Furthermore, toll-like receptor 4 and phosphorylation of nuclear factor-kappa B protein levels were decreased by glucagon-like peptide-1 receptor agonists in ovary. Notably, after glucagon-like peptide-1 receptor agonist intervention, the expression of brown adipose tissue marker levels was considerably raised in the white adipose tissue of polycystic ovary syndrome mice. In conclusion, the hyperinsulinemia and hyperandrogenemia of polycystic ovary syndrome mice were alleviated by glucagon-like peptide-1 receptor agonist intervention, which was associated with mitigating inflammation and stimulating adipose tissue browning.
- Open Access
- 28 July 2022
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 15, 2217-2225
High Serum FABP4 Levels are Negatively Associated with the Reversion from Prediabetes to Normal Glucose Tolerance: A 2-Year Retrospective Cohort Community Study
Objective: To explore the relationship between the level of fatty acid-binding protein 4 (FABP4) and reversion from prediabetes to normal glucose tolerance (NGT). Methods: A two-year retrospective cohort study was conducted on 398 participants with complete information. These 398 participants were divided into an NGT group and an abnormal glucose metabolism (AGM) group after 2 years of follow-up. The baseline level of FABP4 was determined, and the role of FABP4 in predicting reversion from prediabetes to NGT was investigated using an unconditional logistic regression model. Results: Over the two-year follow-up period, 37.4% (149/398) of the participants reverted from prediabetes to NGT. The participants with AGM had a higher baseline level of FABP4 than those with NGT. The baseline level of FABP4 was significantly negatively correlated with reversion from prediabetes to NGT. After adjusting for age, sex, body mass index and waist-to-hip ratio, the level of fasting blood glucose (FBG) [odds ratio (OR) 0.336, 95% confidence interval (CI) (0.196– 0.576)], 2-h post-challenge blood glucose (2hBG) [OR 0.697, 95% CI (0.581– 0.837)], and FABP4 [OR 0.960, 95% CI (0.928– 0.993)] at baseline were significant independent predictors of reversion from prediabetes to NGT. The area under the curve (AUC) value of the receiver operating characteristic curve for FABP4 was 0.605 (95% CI: 0.546– 0.665), and the AUC for FABP4 combined with FBG and 2hBG was 0.716 (95% CI: 0.663– 0.769). Conclusion: A higher baseline level of FABP4 was positively correlated with an adverse profile of diabetes risk factors and negatively correlated with reversion from prediabetes to NGT. FABP4, FBG and 2hBG were predictors of reversion from prediabetes to NGT.
- 28 July 2022
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 15, 2217-2225
Open AccessHigh Serum FABP4 Levels are Negatively Associated with the Reversion from Prediabetes to Normal Glucose Tolerance: A 2-Year Retrospective Cohort Community Study
Objective: To explore the relationship between the level of fatty acid-binding protein 4 (FABP4) and reversion from prediabetes to normal glucose tolerance (NGT). Methods: A two-year retrospective cohort study was conducted on 398 participants with complete information. These 398 participants were divided into an NGT group and an abnormal glucose metabolism (AGM) group after 2 years of follow-up. The baseline level of FABP4 was determined, and the role of FABP4 in predicting reversion from prediabetes to NGT was investigated using an unconditional logistic regression model. Results: Over the two-year follow-up period, 37.4% (149/398) of the participants reverted from prediabetes to NGT. The participants with AGM had a higher baseline level of FABP4 than those with NGT. The baseline level of FABP4 was significantly negatively correlated with reversion from prediabetes to NGT. After adjusting for age, sex, body mass index and waist-to-hip ratio, the level of fasting blood glucose (FBG) [odds ratio (OR) 0.336, 95% confidence interval (CI) (0.196– 0.576)], 2-h post-challenge blood glucose (2hBG) [OR 0.697, 95% CI (0.581– 0.837)], and FABP4 [OR 0.960, 95% CI (0.928– 0.993)] at baseline were significant independent predictors of reversion from prediabetes to NGT. The area under the curve (AUC) value of the receiver operating characteristic curve for FABP4 was 0.605 (95% CI: 0.546– 0.665), and the AUC for FABP4 combined with FBG and 2hBG was 0.716 (95% CI: 0.663– 0.769). Conclusion: A higher baseline level of FABP4 was positively correlated with an adverse profile of diabetes risk factors and negatively correlated with reversion from prediabetes to NGT. FABP4, FBG and 2hBG were predictors of reversion from prediabetes to NGT.
- Open Access
- 1 November 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (11) , 11939-11949
Prevalence and risk factors of diabetes mellitus: a community-based sectional survey
Background: The prevalence of diabetes in China has increased by nearly 18 times from 0.67% in 1980 to 12.8% in 2020. The incidence has occurred with regional diversity, following different climates, diet, and lifestyle. This study aimed to explore the glucose metabolism status and analyze the risk factors for diabetes among over 45-year-old inhabitants from the Shanghai Songjiang district. Methods: A total of 1,213 subjects without diabetes history, thyroid dysfunction history, or other diagnosed diseases were enrolled in this cross-sectional study, all of whom were over 45 years old and from the Shanghai Songjiang district. All subjects participated in a complete physical examination and clinical history collection including name, gender, age, history of drinking and smoking, and presence of other disease. Fasting glucose, postprandial glucose, biochemical, and other metabolic parameters were measured in all subjects. Results: According to the WHO [1990] Standard, the normal glucose regulation (NGR), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), combined glucose impaired (CGI), and newly diagnosis diabetes mellitus (NDDM) were defined and grouped. Among 1,213 subjects in this area, 50.2% had abnormal glucose, including 36.5% with pre-diabetes (PD) and 13.7% with NDDM. We substantiated that hyper-glucose was positively associated with age, body mass index, waist-hip ratio, fat mass, fat percentage, total triglycerides, total cholesterol, low-density lipoprotein, systolic blood pressure, and heart rate in this study. We also found the prevalence of hyper-glucose occurred mainly in women in the 56–60-year-old age group and in men in the 61–65-year-old age group in this area. The overweight rate of male subjects with abnormal glucose was 61.9%, while in females this was 56.3%, especially the central obesity ratio, which reached 91.4% among the female hyper-glucose subjects. Conclusions: In the Shanghai Songjiang district, 56–60-year-old female subjects who were overweight and with central obesity were apt to abnormal glucose regulation. Community-based diabetes management is an important approach for screening diabetes and high-risk factors to reduce the risk and financial burden of individuals and the society.
- 1 November 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (11) , 11939-11949
Open AccessPrevalence and risk factors of diabetes mellitus: a community-based sectional survey
Background: The prevalence of diabetes in China has increased by nearly 18 times from 0.67% in 1980 to 12.8% in 2020. The incidence has occurred with regional diversity, following different climates, diet, and lifestyle. This study aimed to explore the glucose metabolism status and analyze the risk factors for diabetes among over 45-year-old inhabitants from the Shanghai Songjiang district. Methods: A total of 1,213 subjects without diabetes history, thyroid dysfunction history, or other diagnosed diseases were enrolled in this cross-sectional study, all of whom were over 45 years old and from the Shanghai Songjiang district. All subjects participated in a complete physical examination and clinical history collection including name, gender, age, history of drinking and smoking, and presence of other disease. Fasting glucose, postprandial glucose, biochemical, and other metabolic parameters were measured in all subjects. Results: According to the WHO [1990] Standard, the normal glucose regulation (NGR), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), combined glucose impaired (CGI), and newly diagnosis diabetes mellitus (NDDM) were defined and grouped. Among 1,213 subjects in this area, 50.2% had abnormal glucose, including 36.5% with pre-diabetes (PD) and 13.7% with NDDM. We substantiated that hyper-glucose was positively associated with age, body mass index, waist-hip ratio, fat mass, fat percentage, total triglycerides, total cholesterol, low-density lipoprotein, systolic blood pressure, and heart rate in this study. We also found the prevalence of hyper-glucose occurred mainly in women in the 56–60-year-old age group and in men in the 61–65-year-old age group in this area. The overweight rate of male subjects with abnormal glucose was 61.9%, while in females this was 56.3%, especially the central obesity ratio, which reached 91.4% among the female hyper-glucose subjects. Conclusions: In the Shanghai Songjiang district, 56–60-year-old female subjects who were overweight and with central obesity were apt to abnormal glucose regulation. Community-based diabetes management is an important approach for screening diabetes and high-risk factors to reduce the risk and financial burden of individuals and the society.
- Open Access
- 4 December 2020
- Published by Wiley in International Journal of Endocrinology
- Vol. 2020, 1-6
Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy
Purpose. Primary hypertrophic osteoarthropathy (PHO) is a rare, autosomal, recessive genetic disease characterized by digital clubbing, periostosis, and pachydermia. The underlying cause for the pathogenesis of this disease is a defect in prostaglandin E2 (PGE2) degradation, caused by mutations in HPGD or SLCO2A1. In this study, we describe the clinical characteristics, SLCO2A1 mutations, and bone metabolic markers of a PHO pedigree from a Chinese consanguineous twin family. Methods. Whole blood and urine samples were collected from all the family members. All the exons and exon-intron boundaries of the HPGD and SLCO2A1 genes were amplified using polymerase chain reaction (PCR) and sequenced. The biomarkers of mineral and bone metabolism, including calcium, phosphorus, parathyroid hormone (PTH), 25-hydroxyvitamin D (25(OH)D), bone Gla-protein (BGP), C-terminal telopeptide of type I collagen (β-CTX), and urinary calcium/creatinine ratio (Uca/Ucr) were detected. Results. A homozygous (nonsense) mutation in the SLCO2A1 gene (c.1807C >T/p.R603) was detected in the proband. Five heterozygous carriers were also identified among his relatives, including his twin brother. The serum BGP (225.5 ng/ml), β-CTX (4112 pg/ml), and Uca/Ucr (0.63) levels were significantly elevated, while the 25(OH)D (37.1 nmol/L) level was reduced in the proband. The proband’s twin brother displayed increased levels of β-CTX (901 pg/ml) and insufficiency of 25(OH)D (67.29 nmol/L), while the other heterozygous carriers only displayed 25(OH)D insufficiency. Conclusion. The patients with PHO displayed an active state of bone reconstruction. There may be a lack of vitamin D, accompanied by an increase in BGP and β-CTX levels. Heterozygous mutations of SLCO2A1 might lead to mild PHO.
- 4 December 2020
- Published by Wiley in International Journal of Endocrinology
- Vol. 2020, 1-6
Open AccessCharacterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy
Purpose. Primary hypertrophic osteoarthropathy (PHO) is a rare, autosomal, recessive genetic disease characterized by digital clubbing, periostosis, and pachydermia. The underlying cause for the pathogenesis of this disease is a defect in prostaglandin E2 (PGE2) degradation, caused by mutations in HPGD or SLCO2A1. In this study, we describe the clinical characteristics, SLCO2A1 mutations, and bone metabolic markers of a PHO pedigree from a Chinese consanguineous twin family. Methods. Whole blood and urine samples were collected from all the family members. All the exons and exon-intron boundaries of the HPGD and SLCO2A1 genes were amplified using polymerase chain reaction (PCR) and sequenced. The biomarkers of mineral and bone metabolism, including calcium, phosphorus, parathyroid hormone (PTH), 25-hydroxyvitamin D (25(OH)D), bone Gla-protein (BGP), C-terminal telopeptide of type I collagen (β-CTX), and urinary calcium/creatinine ratio (Uca/Ucr) were detected. Results. A homozygous (nonsense) mutation in the SLCO2A1 gene (c.1807C >T/p.R603) was detected in the proband. Five heterozygous carriers were also identified among his relatives, including his twin brother. The serum BGP (225.5 ng/ml), β-CTX (4112 pg/ml), and Uca/Ucr (0.63) levels were significantly elevated, while the 25(OH)D (37.1 nmol/L) level was reduced in the proband. The proband’s twin brother displayed increased levels of β-CTX (901 pg/ml) and insufficiency of 25(OH)D (67.29 nmol/L), while the other heterozygous carriers only displayed 25(OH)D insufficiency. Conclusion. The patients with PHO displayed an active state of bone reconstruction. There may be a lack of vitamin D, accompanied by an increase in BGP and β-CTX levels. Heterozygous mutations of SLCO2A1 might lead to mild PHO.